OWP
AGRX

Old Well Partners’s Agile Therapeutics AGRX Stock Holding History

Old Well Partners’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15
Closed -$89K – 53
2020
Q3 		$89K Buy
15
+2
+15% +$11.5K 0.08% 31
2020
Q2 		$71K Sell
13
-2
-13% -$10.4K 0.06% 25
2020
Q1 		$57K Buy
15
+3
+25% +$17.2K 0.06% 28
2019
Q4 		$58K Buy
+12
New +$41.9K 0.05% 30

Other funds holding AGRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Old Well Partners's AGRX Position: Q4 2020 in Review

Old Well Partners sold out of Agile Therapeutics (AGRX) in Q4 2020, closing a stake of 15 shares — an estimated $89K sold.

Old Well Partners first reported a position in AGRX in Q4 2019 and held it in 4 quarters. The position peaked at $89K in Q3 2020. 76 funds tracked by Wall St. Rank hold AGRX as of Q4 2020.

  • Old Well Partners reported no remaining Agile Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Old Well Partners sold 15 Agile Therapeutics shares in Q4 2020, an estimated $89K.
  • Old Well Partners first reported a position in Agile Therapeutics in Q4 2019 and held it in 4 quarters.
  • Old Well Partners's Agile Therapeutics position peaked at $89K in Q3 2020.
  • 76 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2020.

Based on Old Well Partners's 13F filing for Q4 2020, filed 16 Feb 2021.